Slide 1: Investor Presentation January 2022
For personal use only Investor Presentation January 2022 Sustainable Decentralized Water Solutions
Slide 2: Disclaimer
Disclaimer For personal use only This presentation has been prepared by Fluence Corporation Limited (ASX: FLC). All currencies quoted as “$” are US dollars unless otherwise specified. This presentation may contain forward-looking statements which are identified by words such as ‘may’, ‘could’, ‘beli
Slide 3: Fluence: Disrupting Global Water Infrastructure
Fluence: Disrupting Global Water Infrastructure For personal use only OUR MISSION • We make the world a better place by delivering sustainable water treatment solutions that produce high quality water, while saving energy and improving resilience • We are committed to becoming the global leader in d
Slide 4: Fluence: Fast To Deploy, Profitable Water Solutions
Fluence: Fast To Deploy, Profitable Water Solutions For personal use only Revenue Mix Has Shifted To SPS ex-Ivory Coast Transition To Higher Margin Revenue Illustrative 3% 2% 8% 10% Increasing 16% 12% Gross 25% Margin 65% 82% 80% 2021 excl 2017* Future Target Ivory Coast Smart Products Solutions (SP
Slide 5: Q4 and FY2021 Highlights
Q4 and FY2021 Highlights All numbers are subject to audit For personal use only § Strong revenue growth and backlog in Smart Product Solutions (SPS) leads Revenue Growth1 to 2nd year in a row of positive underlying EBITDA, meeting guidance. $103.2M § Q4 2021 revenues1 of $43.5M up 117% on Q3 2021 an
Slide 6: Strong Growth in Sales of MABR Capacity
Strong Growth in Sales of MABR Capacity All numbers are subject to audit finalization For personal use only MABR Capacity Sold MABR Plants Sold To Date (People served) 957,000 313 56% Growth +67 246 613,000 2020 2021 2020 2021 Installed Added Above left: commissioned plants next to homes and hotel,
Slide 7: Investment Highlights
Investment Highlights For personal use only Proven, Proprietary & Advantaged Water Treatment Products High Growth Market Leading ESG Impact in Water Treatment & Desalination Strong Market Penetration & Inflecting Demand From Partners Attractive Financial Profile and Valuation World Class Leadership
Slide 8: Fluence: Company Overview
For personal use only FLUENCE: COMPANY OVERVIEW
Slide 9: Proven & Proprietary Water & Wastewater Treatment Products
Proven & Proprietary Water & Wastewater Treatment Products Smart, automated wastewater treatment and desalination products deploy fast and require minimal maintenance For personal use only Wastewater Treatment Products Key Advantages: Wastewater Treatment Products 300+ plants sold • Cost savings of
Slide 10: MABR Overview
MABR Overview Our proprietary technology: Membrane Aerated Biofilm Reactor (MABR) For personal use only MABR Development Product Applications SUBRE Upgrade Retrofitting existing WWTPs using MABR SUBRE Plant Using MABR to build Increasing Decentralization new concrete WWTPs Aspiral™ Plant End-to-end
Slide 11: Advantages of MABR
Advantages of MABR MABR enables migration of wastewater treatment from centralized to decentralized, disrupting $150bn market For personal use only Fluence Smart MABR Beats Competing Technologies (1) MABR Competition Fluence vs Competing Technologies Fluence Suez Dupont Capex 17% - 55% lower Scales
Slide 12: Aspiral Overview
Aspiral Overview Our Aspiral product line packages our MABR technology into containerized, modular solutions For personal use only Treats wastewater for Treats wastewater for up Treats wastewater for Treats wastewater for up 30-40 people to 300-400 people up to 750-1,000 people to 2,000-3,000 people
Slide 13: Scaling MABR Technology
Scaling MABR Technology SUBRE applies MABR to larger plants at lower cost and energy use – 14 plants sold to date For personal use only SUBRE enables MABR for larger plants serving up to 250,000 people SUBRE upgrade provides MABR cost, quality and footprint benefits • Capex ~$84/person of capacity (
Slide 14: Established Operations and Manufacturing Capacity
Established Operations and Manufacturing Capacity Our wholly-owned manufacturing facility in China produces MABR modules, SUBRE and Aspiral products For personal use only MABR Manufacturing Since 2017 Manufacturing Line View • MABR produced at wholly owned plant in Changzhou, Jiangsu Province, China
Slide 15: Our Solutions Enable Decentralized Applications
Our Solutions Enable Decentralized Applications Our containerized desalination and water treatment products win on speed of deployment, footprint, and energy use For personal use only NIROBOX SW NIROBOX BW NIROBOX FW Sea Water Brackish Water Fresh water RO desalination RO desalination filtration Thr
Slide 16: Market Shifting to Decentralized Systems
Market Shifting to Decentralized Systems For personal use only Traditional Centralized System Decentralized Systems Network of pre-engineered, small, low cost plants Problems Solutions - Costly to build and operate – years to deploy ü Save up to 90% of piping cost: currently $84bn/year - Infrastruct
Slide 17: Advantages of Decentralized Water & Wastewater Solutions
Advantages of Decentralized Water & Wastewater Solutions Decentralized wastewater treatment is the most cost-effective, energy-efficient, sustainable solution For personal use only Centralized Systems Decentralized Systems Decentralized Urban Water Decentralized advantages: Decentralized advantages
Slide 18: Leading ESG Impact in Water Treatment
Leading ESG Impact in Water Treatment Committed to sustainable water solutions For personal use only Committed to UN SDGs Sustainability Impact from Fluence’s Installations • Fluence’s innovative solutions contribute to the conservation of MABR & NIROBOX resources, energy savings, generation of ener
Slide 19: Go To Market
For personal use only GO TO MARKET
Slide 20: Proven, Targeted Partner-Driven Sales Strategy De-Risks Growth
Proven, Targeted Partner-Driven Sales Strategy De-Risks Growth For personal use only Penetrating priority markets with immediate needs, strong growth, healthy margins Wastewater Both Fresh water treatment & reuse North America Maximize IRR by selling water Middle East versus plants Driven by drought
Slide 21: China Opportunity
China Opportunity China’s 14th Five-Year Plan commits $50 billion to wastewater treatment through 2025 and stresses water reuse For personal use only • High standards. MABR meets required Chinese wastewater treatment standards for non-potable reuse at the lowest cost Market Drivers • China plan is e
Slide 22: Case Study: Aspiral Plants Installed in China
Case Study: Aspiral Plants Installed in China China leadership in wastewater treatment decentralization For personal use only Aspiral Micro treats home Aspiral S1 near homes, Buried Aspiral plant, Highway rest stop Aspiral L4 cluster, Liaoning province Hefei, Anhui province Hangzhou, Zhejiang provin
Slide 23: Southeast Asia Opportunity
Southeast Asia Opportunity Faster pace than China, driven by drought and enforcement of stricter wastewater treatment standards For personal use only • Drought, need for higher wastewater treatment standards and reuse. MABR meets required Chinese wastewater Market Drivers treatment standards for non
Slide 24: Case Study: SUBRE Plants in Sihanoukville, Cambodia
Case Study: SUBRE Plants in Sihanoukville, Cambodia Country’s first biological wastewater treatment plants support 260,000 people: includes world’s largest MABR plant For personal use only Pool Hotel Operating MABR plant Capacity: 40K people Luxury villas Design for world’s largest MABR plant Operat
Slide 25: North America Opportunity
North America Opportunity MABR delivers substantial savings and generates high IRR for wastewater reuse For personal use only • Water scarcity and high water costs drive Market Drivers need for wastewater reuse and desalination as a service • Initial Target: Caribbean and US sunbelt resorts • Priori
Slide 26: Case Study: Selling Water Instead of Capital Equipment
Case Study: Selling Water Instead of Capital Equipment Selling water as a service delivers operating savings shared by customers and Fluence (25%+ IRR) For personal use only Complete Water and Wastewater Solutions Recurring High Margin Revenue Hotel • Wastewater reuse with MABR potentially halves ov
Slide 27: Middle East Opportunity
Middle East Opportunity Urgent need for high-quality decentralized solutions For personal use only • Water Scarcity: urgent need for high- quality decentralized solutions including Market Drivers wastewater reuse; well funded • Target: Arabian gulf states • Sell via Partnerships: Masdar, NUCA (Egypt
Slide 28: World Class Leadership Team
World Class Leadership Team For personal use only Key Management Board of Directors Richard Irving Francesco Fragasso Richard Irving, Chairman & CEO Chairman & CEO CFO • Over 30 years’ tech • 20 years’ finance and venture capital experience in experience renewable energy Paul Donnelly Samantha Tough
Slide 29: Conclusion
Conclusion For personal use only Proven, Proprietary & Advantaged Water Treatment Products High Growth Market Leading ESG Impact in Water Treatment & Desalination Strong Market Penetration & Inflecting Demand From Partners Attractive Financial Profile and Valuation World Class Leadership Team 29